Comparison of transdermal electromotive administration of verapamil and dexamethasone versus intra‐lesional injection for Peyronie's disease
The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
Summary: To compare the efficacy of transdermal electromotive administration and intra‐lesional injection of verapamil plus dexamethasone for the treatment of Peyronie's disease. Patients with Peyronie's disease of less than 2‐year duration were randomized into two groups of transdermal electromotive administration and intra‐lesional injection of verapamil plus dexamethasone. During the 6‐week therapy period, a single weekly dose of 10 mg verapamil and 4 mg dexamethasone solution was administered to 30 patients in each group either by transdermal electromotive method or via the conventional injection method by a syringe connected to a 25 G needle. Evaluations of plaque length, width, and volume, penile curvature, erectile dysfunction and penile deviations were carried out before and after 1 and 3 months of the interventions. Erectile pain was reduced in the electromotive group from a mean of 5.1–1.0 in scale of 10 and from 5.4 to 3.6 in the injection group ( p = 0.006). Regarding plaque length, plaque width, penile curvature plaque volume and erectile dysfunction, the electromotive administration group showed better results which, however, were not statistically significant. ( p > 0.05). Transdermal electromotive drug administration yielded comparable results as against current conventional intra‐lesional injection technique and fared better in controlling erectile pain.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Peyronie's Disease: Etiology, Medical, and Surgical Therapy
HELLSTROM, W. J. G., & BIVALACQUA, T. J. (2000) · Journal of Andrology · doi:10.1002/j.1939-4640.2000.tb03387.x · Cited by 170
Peyronie's disease in men under age 40: characteristics and outcome
Tefekli, A., Kandirali, E., Erol, H., Alp, T., Köksal, T., & Kadıoğlu, A. (2001) · International Journal of Impotence Research · doi:10.1038/sj.ijir.3900635 · Cited by 81 · cited 3×
“INTRODUCTION Peyronie’s disease is characterized by acquired penile curvature, pain on erection, decreased erectile capacity and difficulty in vaginal penetration that are thought to be correlated to local inflammation and subsequent fibrous plaque formation in the tunica albuginea (Gelbard et al., 1990; Tefekli et al…”
Background
Cited by
Evidence-Based Management Guidelines on Peyronie's Disease
Chung, E., Ralph, D., Kagioglu, A., Garaffa, G., Shamsodini, A., Bivalacqua, T., Glina, S., Hakim, L., Sadeghi-Nejad, H., & Broderick, G. (2016) · The Journal of Sexual Medicine · doi:10.1016/j.jsxm.2016.04.062 · Cited by 227
Nonsurgical management of Peyronie’s disease
Tsambarlis, P., & Levine, L. A. (2019) · Nature Reviews Urology · doi:10.1038/s41585-018-0117-7 · Cited by 64
Peyronie’s disease: pharmacological treatments and limitations
Li, E. V., Esterquest, R., Pham, M. N., Panken, E. J., Amarasekera, C., Siebert, A., Bajic, P., & Levine, L. A. (2021) · Expert Review of Clinical Pharmacology · doi:10.1080/17512433.2021.1903873 · Cited by 24
Non-surgical therapies for Peyronie’s disease
Rosenberg, J. E., Ergun, O., Hwang, E. C., Risk, M. C., Jung, J. H., Edwards, M. E., Blair, Y., & Dahm, P. (2023) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd012206.pub2 · Cited by 14
Yang, C.-H., Lin, D.-Y., Lin, Y.-S., Hsu, C.-Y., Tung, M.-C., Tan, K.-T., & Ou, Y.-C. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24010777 · Cited by 7
Metadata
- Authors
- Mehrsai, A. R., Namdari, F., Salavati, A., Dehghani, S., Allameh, F., & Pourmand, G.
- Venue
- Andrology
- Publisher
- Wiley
- Published
- 2012-10-23
- Volume
- 1
- Issue
- 1
- Pages
- 129-132
- ISSN
- 2047-2919 (ISSN-L)
- 2047-2927
- OpenAlex
- W2028448697
- Cited by
- 44
- References
- 2
- FWCI
- 2.66
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Comparison of transdermal electromotive administration of verapamil and dexamethasone versus intra‐lesional injection for Peyronie's disease. https://app.cochat.ai/papers/10.1111/j.2047-2927.2012.00018.x
- The paper
- Mehrsai, A. R., Namdari, F., Salavati, A., Dehghani, S., Allameh, F., & Pourmand, G. (2013). Comparison of transdermal electromotive administration of verapamil and dexamethasone versus intra‐lesional injection for Peyronie's disease. Andrology. https://doi.org/10.1111/j.2047-2927.2012.00018.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.